The use of letrozole in ovarian cancer
Livshits, M.A.; Vasil'ev, B.V.; Guseĭnov, K.D.
Voprosy Onkologii 60(3): 388-391
2014
ISSN/ISBN: 0507-3758 PMID: 25033697 Document Number: 674582
Document emailed within 1 workday
Related Documents
Goswami, S.K.; Das, T.; Chattopadhyay, R.; Sawhney, V.; Kumar, J.; Chaudhury, K.; Chakravarty, B.N.; Kabir, S.N. 2004: A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report Human Reproduction 19(9): 2031-2035Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210
Hartge, P.; Hayes, R.; Reding, D.; Sherman, M.E.; Prorok, P.; Schiffman, M.; Buys, S. 2000: Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial American Journal of Obstetrics and Gynecology 183(5): 1232-1237
Gori, S.; Anastasi, P.; Marrocolo, F. 2004: Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer: the MA-17 study I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 3(4): S27-S31
Yoneyama, K.; Nakamura, H. 2013: An elderly patient with advanced breast cancer who responded to treatment with letrozole-a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(13): 2565-2567
Tsukagoshi, S. 2006: Introduction of new drug: letrozole, a new non-steroidal aromatase inhibitor for the treatment of postmenopausal women with breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(6): 859-863
Novoa Vargas, A.; Font López, K.C.; Amador, D.D. 2011: Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer Ginecologia y Obstetricia de Mexico 79(9): 553-557
Ichinose, Y.; Kobayashi, T.; Fujimoto, A.; Uchida, S.; Sasaoki, T.; Goto, K. 2010: Advanced breast cancer in a patient achieving long-term SD after letrozole administration for liver metastasis developing during anastrozole therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(13): 2913-2916
Kihara, M.; Miyauchi, A. 2008: A case of elderly breast cancer achieving partial response by letrozole with stable disease to anastrozole as neoadjuvant endocrine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(4): 687-690
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177
Rose, P.G.; Hunter, R.E. 1994: Advanced ovarian cancer in a woman with a family history of ovarian cancer, discovered at referral for prophylactic oophorectomy. A case report Journal of Reproductive Medicine 39(11): 908-910
Tanaka, K. 1989: Ovarian cancer--assessment of methods for cytogenetic analysis and chromosome aberrations found in ovarian cancer Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 80: 268-280
Du Bois, A.; Lück, H.J.; Meier, W.; Möbus, V.; Costa, S.; Richter, B.; Warm, M.; Bauknecht, T.; Schröder, W.; Olbricht, S.; Nitz, U.; Jackisch, C. 1997: Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase IIi trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group Seminars in Oncology 24(5 Suppl 15: S15
Chou, Y-Ching.; Chen, Y-Jen.; Lai, C-Ru.; Wang, P-Hui.; Hsin-Chan; Yuan, C-Chung. 2006: Cyclooxygenase-2 expression is higher in ovarian cancer tissue adjacent to endometriosis than in ovarian cancer without comorbid endometriosis European Journal of Obstetrics Gynecology and Reproductive Biology 124(1): 101-105
Ivanov, S.; Batashki, I. 2008: Five years survival in patients with endometrioid ovarian cancer versus patients with serous ovarian cancer Akusherstvo i Ginekologiia 47(5): 9-11
Murakami, F.; Kiyozuka, Y.; Nishimura, H.; Imamura, K.; Yakushiji, M.; Noda, T.; Adachi, S.; Ito, K.; Tamori, N.; Shintani, M. 1993: Etoposide/cis-platinum (CDDP) combined chemotherapy for ovarian cancer: evaluation of optimum schedule for CDDP administration in chronic continuous exposure of ovarian cancer cells to low-dose etoposide in vitro Nihon Sanka Fujinka Gakkai Zasshi 45(2): 125-132
Milsom, I.; Odlind, V. 2008: Oral contraceptives give long-lasting protection against ovarian cancer. use of oral contraceptives can explain reduced incidence of ovarian cancer in Sweden Lakartidningen 105(10): 715-716
Ishii, K.; Aoki, Y.; Takakuwa, K.; Tanaka, K. 2001: Ovarian function after radical hysterectomy with ovarian preservation for cervical cancer Journal of Reproductive Medicine 46(4): 347-352
Rohde, E.; Reincke, I.; Barten, M. 1986: Ovarian metastasis of cancer of the small intestine with simultaneous ovarian pregnancy Zentralblatt für Gynakologie 108(19): 1184-1188
Jin, Z.; Gu, J.; Xin, X.; Li, Y.; Wang, H. 2014: Expression of hexokinase 2 in epithelial ovarian tumors and its clinical significance in serous ovarian cancer European Journal of Gynaecological Oncology 35(5): 519-524